What amount sold does Vala Sciences Inc. report in Form D filings?

The latest linked filings report $2M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Vala Sciences Inc.'s most recent SEC filing?

Vala Sciences Inc.'s most recent Form D filing was on 2017-06-05.

How many investors does Vala Sciences Inc. have?

The most recent Form D filing lists 10 investor(s).

What type of securities does Vala Sciences Inc. offer?

Vala Sciences Inc.'s SEC Form D filings indicate debt offerings.

Vala Sciences Inc.

CIK: 0001654081·Biotechnology·SAN DIEGO, CA·Corporation

Reported Sold

$1,997,500

Total Filings

Identified Offerings

Last Filed

Jun 5, 2017

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 5, 2017Form D/A — Amendment

Reported sold: $1,997,500 · Target: $3,000,000

Rule 506(b)·10 investors

Changed: Reported amount sold, Offering target, Reported investors

Sep 29, 2015Form D — New notice

Reported sold: $1,280,000 · Target: $1,500,000

Rule 506(b)·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$1,997,500

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Mark McWilliams

Related Person

Appears on 2 filings

Jeffrey Price

Related Person

Appears on 2 filings

Michael Geremia

Related Person

Appears on 2 filings

John Westwick

Related Person

Appears on 2 filings

David U'Prichard

Related Person

Appears on 2 filings

Terry Meador

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 5, 2017	Amendment	$3,000,000	$1,997,500	10
Sep 29, 2015	New	$1,500,000	$1,280,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Theravie Pharma, Inc.

Biotechnology

Offering target: $2,250,000

Filed Oct 19, 2026